This page will refresh in 15 seconds and log you into your account.
We believe that riding a wave, building a skateboard, and gliding down snowy mountains can show teens that they are capable of greatness, despite the odds against them.Learn More
Kevin joined STOKED in 2007 and has been hooked ever since.
TEAM UP WITH YOUR
5 EACH WEEK
MAKE A DIFFERENCE FOR
CAUSES THAT MATTER
A majority of cancer research focuses on adult treatments and is done within the walls of individual institutions. In contrast, NPCF funds clinical trials and COLLABORATE with a network of cutting-edge hospitals across the nation to fast track less-toxic, more targeted treatments.
Read The Story
A majority of cancer research focuses on adult treatments and is done within the walls of individual institutions. In contrast, NPCF funds clinical trials and COLLABORATE with a network of cutting-edge hospitals across the nation to fast track less-toxic, more targeted treatments. All to increase the survival rate of children battling cancer. For 25 years and counting, the NPCF has been the one shining light for children who are fighting cancer. They have donated millions of dollars to research and our clinical trials are yielding amazing discoveries that are saving many children’s lives. Through the generous support of donors like you, NPCF has been able to launch trials such as the PEDIATRIC TOTAL CANCER CARE trial at the Moffitt Cancer Center, focused on tissue and blood collection to further personalized medicine for children with cancer. When cancer is suspected, a patient undergoes a biopsy to establish the diagnosis. For some cancers, the therapy is entirely based on the pathologist’s interpretation of this tissue, while some cancers have molecular testing done to either confirm the diagnosis or choose a type of therapy. These test results can have a significant impact on the patient’s choice of therapy. This trial will allow for a centralized collection of tumor tissue for molecular testing. The results may lead to a better understanding of a child’s malignancy or may lead to a better matching of therapy to the patient. The hope is that this may guide the patient to a clinical trial from which they’d be predicted to derive the most benefit.